Control: Clinical Trials

121 trials of Control, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

121 completed. 121 Phase 3, 34 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 3121Completed 121
Phase 234Completed 34

Follow Control: new trials by email Literature Review of Control trials Research Report on Control

Trials (filtered) newest first · largest first

All 121 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Probiotic Supplements in Osteoarthritis
Probiotic Formula, Control - Osteoarthritis, Knee
Phase 3CompletedBeni-Suef University1462025-02-152026-07-24
A Study to Assess Adverse Events and Effectiveness of Intradermally Injected JUVÉDERM® VOLITE™ Gel Filler in Adult Participants For the Improvement of Skin Quality
JUVÉDERM® VOLITE™, Control - Skin Quality Deficit
Phase 2 / Phase 3CompletedAbbVie1352024-07-182026-02-18
Vizol S DIGI EYE Efficacy and Safety Study in Patients With Dry Eye
Vizol S DIGI EYE eye drops, 0,9% saline solution, eye drops - Dry Eye Disease (DED)
Phase 3CompletedJadran Galenski laboratorij d.d.862024-03-202025-07-03
Postoperative Quality of Recovery After Combined Lumbar Plexus-Sciatic Nerve Block (LPB-SNB)
USG Guided Combined LPB-SNB with Isobaric Bupivacaine, Control - Lower Extremity Surgery
Phase 3CompletedUdayana University1002024-03-092024-05-03
SkinTE® for the Treatment of Wagner 1 Diabetic Foot Ulcers (COVER DFUS II)
SkinTE, Control - Diabetic Foot
Phase 3CompletedPolarityTE1202024-02-222026-11-05
Low Dose Versus High Dose Methylene Blue in Septic Patients
Normal saline, Methylene Blue low dose, Methylene Blue high dose - Septic Shock
Phase 2 / Phase 3CompletedNational Cancer Institute, Egypt902023-08-012024-07-05
A Study to Assess Adverse Events and Effectiveness of Injected JUVÉDERM® VOLITE™ Gel Filler for Change in Neck Lines in Adult Chinese Participants
JUVÉDERM® VOLITE™, Control - Neck Lines
Phase 3CompletedAbbVie1592023-04-072025-12-08
Anti-bacterial Clinical Study on Teeth, Tongue, Cheek, Gum, and Saliva
Stannous fluoride toothpaste, Colgate Dental Cream - Plaque, Dental
Phase 3CompletedColgate Palmolive1002023-03-082024-04-15
A Follow-up Study to Describe the Safety of Study Participants Who Received RSVPreF3 Maternal Vaccination (Any Dose) or Controls From Previous RSV MAT Studies During Any Pregnancy Conceived Post Vaccination/Control
RSVPreF3 vaccine, Control - Respiratory Syncytial Virus Infections
Phase 3CompletedGlaxoSmithKline38552023-02-072026-03-17
Dexmedetomidine in Reducing Incidence of Emergence Agitation After Nasal Surgery
Dexmedetomidine - Postoperative Delirium
Phase 3CompletedSecurity Forces Hospital422022-12-222023-04-04
Clinical Efficacy of Ulinastatin for Treatment of Sepsis With Systemic Inflammatory Response Syndrome
Ulinastatin, Placebo - Sepsis
Phase 3CompletedHuashan Hospital1202022-11-102026-09-23
Neoadjuvant Chemoradiation Therapy Combined With Immunotherapy for MSS Ultra-low Rectal Cancer
xintilimab injection, Control - Neoadjuvant Chemoradiation Therapy, Rectal Cancer
Phase 2 / Phase 3CompletedChanghai Hospital2012022-10-012026-01-02
A Study to Assess Adverse Events and Effectiveness of Intradermally Injected JUVÉDERM® VOLITE™ Gel Filler in Adult Participants in China With Fine Lines Around the Mouth
JUVÉDERM® VOLITE™, Control - Perioral Lines
Phase 3CompletedAbbVie1982022-09-072025-12-02
The Lacosamide's Effect on Calcitonin Gene-related Peptide in Migraine Patients
Lacosamide 50 MG Oral Tablet, Ibuprofen 400 mg - Effect of Drug, Migraine Disorders
Phase 3CompletedKafrelsheikh University2002022-06-012024-03-21
Efficacy and Safety of Metformin Versus Empagliflozin on Chronic Kidney Disease Progression
Metformin, Empagliflozin, Control - Renal Insufficiency, Chronic
Phase 2 / Phase 3CompletedTanta University1182022-01-012025-08-14
A Phase 3, Multi-Center Study Evaluating PL9643 in Patients with Dry Eye
Vehicle Ophthalmic Solution, PL9643 Ophthalmic Solution - Dry Eye, Dry Eye Syndromes
Phase 3CompletedPalatin Technologies, Inc5752021-12-302024-10-17
Reducing Acute Kidney Injury Occurence by Administering Angiotensin II
Angiotensin II, Control - Cardiac Surgery, Vasoplegia
Phase 3CompletedUniversität Münster642021-12-272023-03-24
Effects of Electrical Stimulation and Vitamin D Supplementation on Bone Health Following Spinal Cord Injury.
NMES, Vitamin D, Passive movement - Spinal Cord Injury
Phase 2 / Phase 3CompletedVA Office of Research and Development62021-10-012026-01-23
Opioid-Free Anesthesia in Cardiac Surgery
Dexmédétomidine 0.5 g/kg + lidocaine 1.5 mg/kg, Remifentanil - Anesthesia
Phase 3CompletedUniversity Hospital, Rouen2682021-07-222026-03-31
Effects of a Composition on the Oral Microbiome, pH, Nitrite/Nitrate Ratio, Elastases and Inflammation in Oral Dysbiosis
Test composition Saliactive® (olive product, betaine and xylitol), Placebo, Control - Oral Dysbiosis
Phase 2 / Phase 3CompletedMucosa Innovations, S.L.1002021-07-132024-07-08

Showing 20 of 121. Sign in to see all of them.

Conditions studied

Myocardial Infarction (4)  ·  Premature Birth (4)  ·  COVID-19 (3)  ·  HIV Infections (3)  ·  Obesity (3)  ·  Pain (3)  ·  Pain, Postoperative (3)  ·  Anemia (2)  ·  Coronary Disease (2)  ·  Coronavirus Infections (2)  ·  Dental Plaque (2)  ·  Depression (2)  ·  Dry Eye Syndromes (2)  ·  Fatigue (2)  ·  Gingivitis (2)

Sponsors

Medline Industries (4)  ·  Royan Institute (4)  ·  AbbVie (3)  ·  Assistance Publique - Hôpitaux de Paris (2)  ·  Assiut University (2)  ·  Bio-Medical Research, Ltd. (2)  ·  Children's Hospital of Philadelphia (2)  ·  Colgate Palmolive (2)  ·  Dompé Farmaceutici S.p.A (2)  ·  Fresenius Kabi (2)  ·  GlaxoSmithKline (2)  ·  Islamic Azad University, Sanandaj (2)  ·  Johns Hopkins University (2)  ·  Universidad de Granada (2)  ·  University of Pennsylvania (2)

Countries

United States (45)  ·  France (13)  ·  Canada (11)  ·  Germany (11)  ·  Spain (11)  ·  China (9)  ·  Egypt (8)  ·  Brazil (6)  ·  Italy (6)  ·  Belgium (5)  ·  United Kingdom (5)  ·  Iran (4)  ·  Poland (4)  ·  South Korea (4)  ·  Australia (3)

Top investigators

Hamid Gourabi, PhD (3)  ·  Daniel Romer, PhD (2)  ·  Hossein Baharvand, PhD (2)  ·  Jerilynn Radcliffe, PhD (2)  ·  Julio J Ochoa, Ph.D. (2)  ·  A Bhansali (1)  ·  Abbot R. Laptook, MD (1)  ·  Abhik Das, PhD (1)  ·  Aisha K Yousafzai, PhD (1)  ·  Alexander R Precioso, MD PhD (1)  ·  Alexander Zarbock, MD (1)  ·  Alexandra L Jenkins, PhD, RD (1)  ·  Anders B. Gottlieb Hansen, Ph.d.-student, cand.techn.soc (1)

Results publications

PMID 11914403, PMID 12165594, PMID 12807523, PMID 15951714, PMID 16221780, PMID 17079582, PMID 17679633, PMID 17955107, PMID 18515527, PMID 18534246, PMID 18720323, PMID 18762517, PMID 18829776, PMID 19020525, PMID 19252411, PMID 19364999, PMID 19618698, PMID 19944358, PMID 19948631, PMID 20126343, PMID 20495811, PMID 20921569, PMID 21377930, PMID 21410418, PMID 21479243, PMID 21566232, PMID 21674393, PMID 21806579, PMID 21809337, PMID 22103808, PMID 22116817, PMID 22186969, PMID 22221277, PMID 22352784, PMID 22563751, PMID 22646631, PMID 22846542, PMID 22959311, PMID 23153149, PMID 23157895, PMID 23200183, PMID 23291425, PMID 23339225, PMID 23440355, PMID 23465551, PMID 23549132, PMID 23828106, PMID 23896100, PMID 23953384, PMID 24019415

NIH funding

2009 (2), 2014 (1), M01RR000030 (1), M01RR000039 (1), M01RR000044 (1), M01RR000070 (1), M01RR000080 (1), M01RR000633 (1), M01RR000750 (1), M01RR006022 (1), M01RR007122 (1), M01RR008084 (1), M01RR016587 (1), R01DA012403 (1), R01DA013496 (1)